Skip to content

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06050135
Enrollment
260
Registered
2023-09-22
Start date
2024-05-20
Completion date
2027-02-10
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parenthood Status, Quality of Life

Keywords

Roadmap to Parenthood, Decision aid, Planning tool

Brief summary

This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.

Interventions

OTHERRoadmap to Parenthood

web-based decision support

web-based informational booklet about young adult cancer survivorship

Sponsors

Stanford University
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Assigned female at birth * Aged 18 to 45 years old * Understands verbal and written English * History of a cancer diagnosis. * Completed cancer treatment(s) with known or uncertain gonadotoxic effects (e.g., systemic chemotherapy, surgery or radiation affecting reproductive organs or hormone regulation, stem cell or bone marrow transplant, and/or immunotherapy) * Interested in having a future child (or more children) or uncertain about family building plans * Access to the Internet and use of a computer, tablet, or smartphone * Ability to understand and the willingness to personally sign the written IRB-approved informed consent document

Exclusion criteria

* Currently undergoing cancer treatment excluding long term adjuvant or maintenance therapies, such as tamoxifen * Significant physical or mental disability that prevents completion of study activities

Design outcomes

Primary

MeasureTime frameDescription
Decision Conflict Scale12 monthsDecisional Conflict Scale is a validated survey that assesses personal uncertainty in making healthcare decisions; modifiable factors contributing to uncertainty; and the quality of the decision made. The survey has 16 questions, with responses on a 5 point scale ranging from "strongly agree" (1) to "strongly disagree" (5). Total scores range from 16 to 80, with higher scores indicating greater uncertainty (worse outcome)

Secondary

MeasureTime frameDescription
Planning Behaviors for Future Family Building12 monthsYes and No (Y/N) question of whether participants completed "next step" planning behaviors aligned with their family-building goals
Patient-Reported Outcomes Measure-29 (PROMIS-29) Quality of Life12 monthsPROMIS-29 assesses seven domains of health-related quality of life including physical function, anxiety, depression, ability to participate in social roles and activities (social participation), fatigue, pain interference, and pain intensity. Items are scored on a 5-point scale (range 1-5). From the sum of the answers to each question in the domain, the total raw score for each domain is calculated, resulting in seven domain scores, each between 4 and 20

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCatherine Benedict, PhD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026